Drugs / Live attenuated human rotavirus vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00134732 | Jul 2005 → May 2006 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live attenuated human rotavirus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00134732 ↗ |
| Modality | Vaccine | “GlaxoSmithKline (GSK) Biologicals has developed a vaccine against human rotavirus gastroenteritis.” NCT00134732 ↗ |
| Route | Oral | “Oral Live Attenuated Human Rotavirus (HRV) Vaccine” NCT00134732 ↗ |